01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Wattiaux R, Jadot M, Warnier-Pirotte MT, Wattiaux-De Coninck
S (1997) Cationic lipids destabilize lysosomal membrane in
vitro. FEBS Lett 417, 199-202.
Webb A, Cunningham D, Cotter F, Clarke PA, di Stefano F,
Ross P, Corbo M, Dziewanowska Z (1997) BCL-2 antisense
therapy in patients with non-Hodgkin lymphoma. Lancet
349, 1137-1141.
Webster MK and Donoghue DJ (1998) Constitutive activation of
fibroblast growth factor receptors in human developmental
syndromes. Gene Ther Mol Biol 1, 365-379.
Weih F, Ryseck R-P, Chen L, and Bravo R (1996) Apoptosis of
nur77/N10-transgenic thymocytes involves the Fas/Fas
ligand pathway. Proc Natl Acad Sci USA 93, 5533-5538.
Weir L, Chen D, Pastore C, Isner JM, Walsh K (1995)
Expression of gax, a growth arrest homeobox gene, is rapidly
down-regulated in the rat carotid artery during the
proliferative response to balloon injury. J Biol Chem 270,
5457-5461.
Weiss DJ, Liggitt D, Clark JG (1997) In situ histochemical
detection of β-galactosidase activity in lung: assessment of
X-Gal reagent in distinguishing lacZ gene expression and
endogenous β-galactosidase activity. Hum Gene Ther 8,
1545-1554.
Weitzman MD, Fisher KJ, Wilson JM (1996) Recruitment of
wild-type and recombinant adeno-associated virus into
adenovirus replication centers. J Virol 70, 1845-1854.
Werness BA, Levine AJ, Howley PM (1990) Association of
human papillomavirus types 16 and 18 E6 proteins with p53.
Science 248, 76-79.
Westerman KA, Leboulch P (1996) Reversible immortalization
of mammalian cells mediated by retroviral transfer and sitespecific
recombination. Proc Natl Acad Sci USA 93, 8971-
8976.
White EM, Allis CD, Goldfarb DS, Srivastva A, Weir JW, and
Gorovsky MA: Nucleus-specific and temporally restricted
localization of proteins in Tetrahymena macronuclei and
micronuclei. J Cell Biol 109: 1983-1992, 1989.
White RJ (1998) Control of growth and proliferation by the
retinoblastoma protein. Gene Therapy Mol Biol 1, 613-628.
White, E. (1993) Death-defying acts: a meeting review on
apoptosis. Genes Dev. 7, 2277-2284.
Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H.,
Raybuck, M., Weinberg, R.A. and Harlow, E. (1988)
Association between an oncogene and an anti-oncogene: the
adenovirus E1A proteins bind to the retinoblastoma gene
product. Nature 334, 124-129.
Wieder R, Wang H, Shirke S, Wang Q, Menzel T, Feirt N,
Jakubowski AA, Gabrilove JL (1997) Low level expression
of basic FGF upregulates Bcl-2 and delays apoptosis, but
high intracellular levels are required to induce transformation
in NIH 3T3 cells. Growth Factors 15, 41-60.
Wilcock D and Lane DP (1991) Localization of p53,
retinoblastoma and host replication proteins at sites of viral
replication in herpes-infected cells. Nature 349, 429-431.
Will K and Deppert W (1998) Analysis of mutant p53 for MAR-
DNA binding: determining the dominant-oncogenic function
of mutant p53. Gene Ther Mol Biol Vol 1, 543-549.
Gene Therapy and Molecular Biology Vol 1, page 161
161
Will K, Warnecke G, Albrechtsen N, Boulikas T, and Deppert W
(1998) High affinity MAR/SAR-binding is a common
property of murine and human mutant p53. J Cell Biochem
In press
Williams SA, Chang L, Buzby JS, Suen Y, Cairo MS (1996)
Cationic lipids reduce time and dose of c-myc antisense
oligodeoxynucleotides required to specifically inhibit
Burkitt's lymphoma cell growth. Leukemia 10, 1980-1989.
Wills KN, Maneval DC, Menzel P, Harris MP, Sutjipto S,
Vaillancourt M-T, Huang W-M, Johnson DE, Anderson SC,
Wen SF, Bookstein R, Shepard HM, Gregory RJ (1994)
Development and characterization of recombinant
adenoviruses encoding human p53 for gene therapy of
cancer. Hum Gene Ther 5, 1079-1088.
Wilson C, Bellen HJ and Gehring WJ (1990) Position effects on
eukaryotic gene expression. Annu Rev Cell Biol 6, 679-714.
Wilson JM (1995) Gene therapy for cystic fibrosis: challenges
and future directions. J Clin Invest 96, 2547-2554.
Wilson JM, Danos O, Grossman M, Raulet DH, Mulligan RC
(1990) Expression of human adenosine deaminase inmice
reconstituted with retrovirus-transduced hematopoietic stem
cells. Proc Natl Acad Sci USA 87, 439-443.
Wilson JM, Grossman M, Raper SE, Baker JR, Newton RS, and
Thoene JG (1992) Clinical protocol. Ex vivo gene therapy of
familial hypercholesterolemia. Hum Gene Ther 3, 179-222.
Wiltrout RH, Gregorio TA, Fenton RG, Longo DL, Ghosh P,
Murphy WJ, Komschlies KL (1995) Cellular and molecular
studies in the treatment of murine renal cancer. Semin Oncol
22, 9-16.
Witte ON and Baltimore D (1977) Mechanism of formation of
pseudotypes between vesicular stomatitis virus and murine
leukemia virus. Cell 11, 505-511.
Wolfe JH, Sands MS, Barker JE, Gwynn B, Rowe LB, Vogler
CA, and Birkenmeier EH (1992) Reversal of pathology in
murine mucopolysaccharidosis type VII by somatic cell gene
transfer. Nature 360, 749-753.
Wolff JA, Fisher LJ, Xu L, Jinnah HA, Langlais PJ, Iuvone PM,
O'Malley KL, Rosenberg MB, Shimohama S, Friedmann T,
Gage FH (1989) Grafting fibroblasts genetically modified to
produce L-dopa in a rat model of Parkinson disease. Proc
Natl Acad Sci USA 86, 9011-9014.
Wu P, de Fiebre CM, Millard WJ, King MA, Wang S, Bryant
SO, Gao YP, Martin EJ, Meyer EM (1996) An AAV
promoter-driven neuropeptide Y gene delivery system using
Sendai virosomes for neurons and rat brain. Gene Ther 3,
246-253.
Wu X and Levine AJ (1994) p53 and E2F-1 cooperate to mediate
apoptosis. Proc Natl Acad Sci USA 91, 3602-3606.
Wyman TB, Nicol F, Zelphati O, Scaria PV, Plank C, Szoka FC
Jr (1997) Design, synthesis, and characterization of a
cationic peptide that binds to nucleic acids and permeabilizes
bilayers. Biochemistry 36, 3008-3017.
Xiao H, Pearson A, Coulombe B, Truant R, Zhang S, Regier JL,
Triezenberg SJ, Reinberg D, Flores O, Ingles CJ, Greenblatt
J (1994) Binding of basal transcription factor TFIIH to the
acidic activation domains of VP16 and p53. Mol Cell Biol
14, 7013-7024.